According to the report titled ‘Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025,’ available with MarketStudyReport, global vaccines market is expected to reach a valuation of USD 48 billion during the period 2019-2025.
 

Increasing cognizance of the diseases and focus on reducing the health risks, in tandem with improved healthcare infrastructure, and constant R&D for vaccines are bolstering the growth of global vaccines market.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/2060552/
 

The report contains a detailed description of determinants influencing the market dynamics and the restraints hampering the development of the overall industry. It outlines the opportunities available for the businesses to generate lucrative returns during the forecast period as well as the challenges likely to pose as a threat to the revenue inflow.
 

It entails a comparative analysis of the past data for 2015-2018 and the current scenario to make predictions about growth rate through the year 2025. Clear details about the development of the vaccine market with respect to revenue share, market size, and anticipated demand are also provided. 
 

As per expert researchers, the top vaccines in worldwide vaccines industry include Shingrix, Boostrix, Cervarix, Pentaxim, Biken Ha, Bexsero, Bio Thrax, Zostavax, Rotateq, Jebik, Infanrix, Pentacel, Imovax, Ticovac, Pediarix, Dukoral, Trumenba, Synfloric, Flumist/Fluenz, Hexaxim, Rotarix, and Menveo. Of these, Prevnar / Prevnar 13 garnered the largest market share, while Shingrix was anticipated to gain blockbuster vaccine status in the year 2019.
 

On further research, the assessment of promising vaccines in the clinical development stages and major players participating in it are also revealed. Prominent data concerning partnerships, exclusive licensing agreements, distributions, collaborations, and mergers & acquisitions is presented in the document. 
 

Lastly, the study enumerates information about key players in worldwide vaccines market such as Biological E. Limited, Merck & Co. Inc., Astellas Pharma Inc., Bavarian Nordic A/S, Emergent BioSolutions Inc., GlaxoSmithKline (GSK) plc, Panacea Biotec Limited, Mitsubishi Tanabe Pharma Corporation, AstraZeneca plc, Sinovac Biotech Ltd., Pfizer Inc., Valneva SE, Seqirus, Sanofi Pasteur, Bharat Biotech International Limited, and Serum Institute of India. These companies are evaluated on the basis of their portfolios, the market value of the vaccines, and business overview. Of these, GlaxoSmithKline (GSK) plc is poised to lead the market forecast through 2025